Krystal Biotech (KRYS) Upgraded to Buy: What Does It Mean for the Stock?
Krystal(KRYS) ZACKS·2024-08-08 01:00
Krystal Biotech, Inc. (KRYS) appears an attractive pick, as it has been recently upgraded to a Zacks Rank #2 (Buy). This rating change essentially reflects an upward trend in earnings estimates -- one of the most powerful forces impacting stock prices. A company's changing earnings picture is at the core of the Zacks rating. The system tracks the Zacks Consensus Estimate -- the consensus measure of EPS estimates from the sell-side analysts covering the stock -- for the current and following years. Since a c ...